Ascension Life Fund
VC Fund
London, United Kingdom
Ascension Life Fund is a VC fund in London focused on Medical and Biotechnology. Ascension Life Fund invests into a portfolio of at least 8 high potential HealthTech and Life Science companies per year. It is a new specialist fund combining the sector expertise of the Investment Team with Ascension’s reputation.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Ascension Life Fund invests in
Stages Ascension Life Fund invests in
Countries Ascension Life Fund invests in
Investment Focus
Industry
- Medical 2 (40%)
- Biotechnology 2 (40%)
- Medical Device 2 (40%)
- Clinical Trials 2 (40%)
- Analytics 1 (20%)
Stage
- Seed 3 (60%)
- Series A 1 (20%)
- Funding Round 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Qureight
|
Qureight is an imaging analytics company. It also aims to develop a new improved and streamlined version of its analytical platform – harnessing the ability of AI and advanced processing tools to gain new insights into respiratory diseases such as Idiopathic Pulmonary Fibrosis (IPF) and lung cancer. | $8.5M / Series A / Apr 16, 2024 | |
Neuronostics
|
Neuronostics Ltd is a newly established University of Exeter (UK) spin-out, focussed on the development and commercialisation of a novel and potentially revolutionary seizure susceptibility assessment technology called #BioEP. | $2.7M / Seed / Apr 05, 2024 | |
NunaBio
|
NunaBio operates as a privately-owned specialist DNA development company. NunaBio engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities. | $2.4M / Seed / Apr 20, 2023 | |
Nebu-Flow
|
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders. The company is a developer of the technology control of the droplet size for deep lung deposition by enabling injection-free systemic drug delivery through inhalation routes for cardiovascular and central nerve system disorders. Nebu-Flow iscommitted to minimizing the environmental impact of activities whilst continuing to create a user-friendly and high-performing Nebuliser. | $2.1M / Seed / May 10, 2022 | |
Amlo Biosciences
|
AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma. | $3.2M / Apr 21, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ascension Life Fund invest in?
Ascension Life Fund invests primarily in Medical, Biotechnology and Medical Device startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Ascension Life Fund last invest?
The most recent investment recorded for Ascension Life Fund closed in Apr 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
